Gatifloxacin PCD Pharma Franchise Company
Cafoli Lifecare offers a Gatifloxacin PCD pharma franchise built on 9 formulations across tablets, eye drops and combinations, all manufactured at WHO-GMP certified facilities. This gives franchise partners a versatile fluoroquinolone antibiotic line for ophthalmology and general infection care.
What is Gatifloxacin?
Gatifloxacin is a fourth-generation fluoroquinolone antibiotic that inhibits the bacterial enzymes DNA gyrase and topoisomerase IV, blocking DNA replication. It has enhanced activity against Gram-positive cocci and atypical organisms and is widely used topically in the eye. Read its profile on PubChem.
Therapeutic Applications
Gatifloxacin eye drops are prescribed for bacterial conjunctivitis, keratitis and peri-operative ophthalmic prophylaxis, while oral formulations are used for respiratory, urinary and other bacterial infections. It is also formulated in combinations with corticosteroids for inflamed ocular infections. Prescriptions come mainly from ophthalmologists, general physicians and ENT specialists.
Why Gatifloxacin is a High-Potential Molecule for Distributors
Gatifloxacin is a first-choice topical antibiotic in ophthalmology — eye infections and pre/post-cataract-surgery prophylaxis generate steady, high-volume demand, and India performs a very large number of cataract procedures each year. The ophthalmic niche is less price-eroded than oral antibiotics, and steroid combinations add value SKUs. That makes gatifloxacin a reliable, margin-friendly molecule, especially for distributors serving eye hospitals.
Why Choose Cafoli Lifecare
Cafoli Lifecare provides territory-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, complete promotional inputs and the backing of 1000+ franchise partners across India.
References
- PubChem: Gatifloxacin
- PubMed: Gatifloxacin literature
Our formulations of Gatifloxacin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: